Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone. The middle of the week is here, which is, generally, a busy time. Our morning, in fact, got off to an usually interesting start thanks to National Public Radio and WNYC, a local affiliate, which called us to discuss the Merck reorganization (you can listen here). We do this sort of thing, now and again, in case you were not aware. We are also available for conferences, bar mitzvahs and satires. While you ponder the possibilities, here are some tidbits to start the day. Hope you have a smashing time at work and do stay in touch... J&J Says Dispute With Boehringer May Cause Doxil Shortage (Bloomerg News) Merck Drug Triggers Response In 24 Percent Of Lung Cancer Patients (Reuters) South Korea Halts Sales Of Pfizer's Zithromax Over Dosage Info (Yonhap News) US Court Lifts Block On Sales Of Rival To AstraZeneca's Nexium (Pharma Times) J&J Faces Public Interest Lawsuit In India Over Consumer Packaging (Economic Times) Another Indian Drugmaker Is Cited For GMP Violations (InPharma Technologist) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs